UBS AM’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-21,058
Closed -$248K 2715
2022
Q3
$248K Hold
21,058
﹤0.01% 2547
2022
Q2
$238K Hold
21,058
﹤0.01% 2539
2022
Q1
$630K Hold
21,058
﹤0.01% 2370
2021
Q4
$558K Hold
21,058
﹤0.01% 2512
2021
Q3
$764K Sell
21,058
-9,403
-31% -$341K ﹤0.01% 2295
2021
Q2
$1.32M Buy
30,461
+122
+0.4% +$5.3K ﹤0.01% 2049
2021
Q1
$1.04M Sell
30,339
-243
-0.8% -$8.31K ﹤0.01% 2070
2020
Q4
$1.07M Buy
30,582
+21,087
+222% +$738K ﹤0.01% 1954
2020
Q3
$228K Sell
9,495
-1,176
-11% -$28.2K ﹤0.01% 2372
2020
Q2
$195K Sell
10,671
-195
-2% -$3.57K ﹤0.01% 2393
2020
Q1
$170K Buy
10,866
+2,058
+23% +$32.1K ﹤0.01% 2324
2019
Q4
$188K Sell
8,808
-580
-6% -$12.4K ﹤0.01% 2485
2019
Q3
$176K Buy
9,388
+1,112
+13% +$20.8K ﹤0.01% 2602
2019
Q2
$216K Buy
8,276
+2,280
+38% +$59.5K ﹤0.01% 2518
2019
Q1
$154K Hold
5,996
﹤0.01% 2522
2018
Q4
$138K Hold
5,996
﹤0.01% 2479
2018
Q3
$192K Hold
5,996
﹤0.01% 2459
2018
Q2
$170K Sell
5,996
-552
-8% -$15.6K ﹤0.01% 2506
2018
Q1
$232K Buy
6,548
+3,848
+143% +$136K ﹤0.01% 2320
2017
Q4
$105K Buy
+2,700
New +$105K ﹤0.01% 2396
2016
Q2
Sell
-7,500
Closed -$156K 2633
2016
Q1
$156K Sell
7,500
-167,014
-96% -$3.47M ﹤0.01% 2495
2015
Q4
$5.29M Sell
174,514
-20,916
-11% -$634K 0.01% 1055
2015
Q3
$4.83M Hold
195,430
0.01% 1060
2015
Q2
$6.27M Hold
195,430
0.01% 1008
2015
Q1
$6.98M Hold
195,430
0.01% 976
2014
Q4
$4.44M Sell
195,430
-3,210
-2% -$72.9K ﹤0.01% 1063
2014
Q3
$3.85M Buy
198,640
+8,620
+5% +$167K ﹤0.01% 1090
2014
Q2
$6.9M Hold
190,020
0.01% 961
2014
Q1
$7.37M Hold
190,020
0.01% 941
2013
Q4
$5.42M Hold
190,020
0.01% 989
2013
Q3
$6.8M Buy
190,020
+43,460
+30% +$1.56M 0.01% 903
2013
Q2
$4.9M Buy
+146,560
New +$4.9M 0.01% 957